BROKERS CHOICE: MAHINDRA, NYKAA, TRENT, SKIPPER, TATAPOWER, JSWENERGY, POLYCAB, ZOMATO

AHMEDABAD, 8 OCTOBER:

CLSA on M&M: Upgrade to Outperform on Company, raise target price at Rs 3400 (Positive)

MS on Nykaa: Maintain Overweight on Company, target price at Rs 216 (Positive)

MS on TRENT: Maintain Overweight on Company, target price at Rs 8032 (Positive)

Nuvama on Skipper: Initiate Buy on Company, target price at Rs 650 (Positive)

Nomura on Tata Power: Initiate Buy on Company, target price at Rs 560 (Positive)

Nomura on JSW Energy: Initiate Buy on Company, target price at Rs 885 (Positive)

HSBC on Zomato: Maintain Buy on Company, target price at Rs 330 (Positive)

HSBC on Polycab: Maintain Buy on Company, raise target price at Rs 7800 (Positive)

HSBC on KEI Ind: Maintain Hold on Company, raise target price at Rs 4350 (Positive)

JPMorgan on Paints: Positive on the long-term growth potential of the paints industry (Positive)

Jefferies on Pharma: Cipla, Zydus and Sun Pharma continues to gain market share in Albuterol and Lanreotide (Positive)

Nomura India Strategy: With renewed interest in HK/China stocks, see risk of some near-term underperformance for India (Neutral)

BofA on Godrej prop: Maintain Neutral on Company, target price at Rs 3500 (Neutral)

HSBC on KEI Ind: Maintain Hold on Company, target price at Rs 1900 (Neutral)

Emkay on Tata Motors: Maintain Buy on Company, target price at Rs 1175 (Neutral)

MOSL on Tata Motors: Maintain Neutral on Company, target price at Rs 990 (Neutral)

Citi on Nykaa: Maintain Sell on Company, target price at Rs 165 (Neutral)

UBS on Auro Pharma: Maintain Sell on Company, target price at Rs 1333 (Negative)

UBS on Tata Motors: Maintain Sell on Company, target price at Rs 825 (Negative)

Jefferies on Pharma: Lupin market share loss accelerates (Negative)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)